Why don't we have 21 days to comment on the proposed nuclear site, asks Mandi Smallhorne.
'Fashionable ideologies' are just smokescreens and won't solve SA's jobs crisis.
The new political powerhouses must respect SA's democratic insitutions, says Solly Moeng.
Basadifeela Letsoalo has been appointed as executive director for human capital and transformation, says Adcock Ingram.
Health and care brands company Ascendis Health has completed all conditions pertaining to the R7.3bn acquisitions of two European companies.
The Competition Tribunal has approved, what is believed to be one of the largest mergers in history, between Bonitas Medical Fund and the ailing Liberty Medical Scheme.
Pfizer has agreed to buy an antibiotics business from AstraZeneca for $72m as well as other pay outs, seeking to add to its pipeline of treatments intended to fight infections.
Pfizer has claimed the pharmaceutical industry’s latest big prize, beating out a group of rivals and bought Medivation and its blockbuster cancer drug for $14bn.
Momentum Health denies sharing client data with the rest of its insurance business, as was claimed by the Council of Medical Schemes.
Swiss drugmaker Novartis said it was not under investigation over bribery allegations in Turkey and that it considered the matter closed
AstraZeneca has invested another $140m in Moderna Therapeutics, the US biotech "unicorn" which is developing drugs based on a molecule known as messenger RNA.
Ascendis Health says its R1.2bn rights issue, which closed last week, has been more than three times oversubscribed.
Pfizer has reported better-than-expected quarterly revenue and profit, driven by sales of newer drugs and the acquisition of hospital products company Hospira.
Pfizer's quarterly revenue has edged up about 11%, driven by sales of newer drugs and the acquisition of hospital products company Hospira last year.
Traditional firms are feeling the heat with "virtual" legal service providers on the rise.
The proposed sugar tax is seen as yet another financial ambush on citizens.
SA investors can now buy Krugerrands at a 10% discount - but caution is advised.
A local entrepreneur tells how he has kept his small, black-owned mining business afloat.
The 100MW Kathu Solar Park in Northern Cape will keep the lights on in 50 000 households.
Wayde van Niekerk presents SA with a much-needed symbol of unity, says Solly Moeng.
An analyst weighs in on renewable energy options as lucrative nuclear deals beckon.
Companies practising gender discrimination turn their backs on a vast pool of talent.
Pharmaceutical workers launched an indefinite wage strike, likely affecting production and distribution depots, but Adcock Ingram has not been affected.
GlaxoSmithKline has reported second-quarter earnings that beat analysts’ estimates and raised its forecast for the year as sales of new products doubled.
When Deona Duke woke up from a medically-induced coma to begin recovering from burns that covered almost a third of her body, one of her treatments was hurling snowballs at penguins.
It doesn't matter
Previous results ·
Suggest a vote
Get your financial questions answered.
News delivered really simply.
Easy-to-use personal finance tools.
You choose what you want.
Lost? Confused? Problems? Let us help you.